Canadian researchers found that people with diabetes fell into the high-risk category for cardiovascular disease ( CVD ) 15 years earlier than those without diabetes.

A new potentially powerful new therapy for diabetes and peripheral vascular disease which promotes nerve development, holds potential for treating diabetes and other diseases.

For those lucky few who make it to the century mark, a crucial gene variation relating to HDL cholesterol levels may play an important part in their longevity.

Despite the publication of increasingly aggressive guidelines for lowering blood pressure in people with diabetes, this condition remains substantially unimproved.

Novartis said last Friday its Exforge antihypertensive medication had received approval from the U.S. Food and Drug Administration (FDA). Exforge combines valsartan and amlodipine besylate in one pill. “Exforge is expected to be available to patients in the U.S. in September 2007.

Researchers identified a predictive relationship between small pupil size in adolescents with type 1 diabetes and the presence of microalbuminuria and retinopathy 12 years later.

A gradual dose escalation of pramlintide increases its tolerability, while the concomitant reduction of insulin dose increases the safety and results in favorable glycemic and body weight changes

More aggressive screening and treatment is needed in children with type 2 diabetes to prevent complications as they get older.

Immature sucking patterns are often seen in infants whose mothers developed diabetes during pregnancy and had to be treated with insulin, new research indicates.

In the workplace there seems to be some confusion about whether diabetes is a legitimate disability and with concern about whether it is overly expensive, hazardous and disruptive to accommodate the illness.